Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Murine coronavirus (MCoV)

Bacterial immunostimulant increases activity of macrophages in lung tissue

    • Education
    • General Internal Medicine
    • Infectiology
    • News
    • Pneumology
    • RX
    • Studies
  • 3 minute read

Strengthening the body’s defenses with the help of orally ingested bacterial extracts can help fight respiratory infections in humans. In a recently published study, the underlying mechanisms of action of this immunological benefit were analyzed using murine coronavirus (MCoV) in a mouse model.

That ingestion of the bacterial lysate OM-85-BV (Broncho-Vaxom®) in humans results in both a significantly lower incidence of recurrent respiratory infections and a lower overall duration of respiratory infections has been demonstrated in previous studies [1–3]. To investigate what cellular and molecular mechanisms are involved, treatment effects of OM-85-BV on murine coronavirus (MCoV) A59 im were analyzed. In this regard, treatment with OM-85-BV was shown to result in a reduction in viral load, an accumulation of interstitial macrophages in lung tissue, and an associated more rapid response of interferon type-I signaling [4].

Massive viral reduction on day 4 and 10

74 laboratory mice were divided into treatment and control groups in a 1:1 ratio. Experimental animals in the verum condition received 7.2 mg orally administered OM-85-BV (dissolved in 200 μL 3% D-mannitol) for a period of 10 days [4]. Mice in the control condition received 200 μL 3% D-mannitol. Tissue samples were analyzed at 2, 4, and 10 days after intranasal MCoV infection, respectively, by quantitative PCR (qPCR), RNA sequencing, histology, and flow cytometry. To measure viral load, quantitative PCR (qPCR) was used to determine the two viral markers Nsp12 and PolyU in the lungs. This showed that mice with an immune system trained by the bacterial lysate had a massive viral reduction on day 4 that persisted on day 10.

Lung-specific accumulation of interstitial macrophages.

Macrophages represent the first line of defense until specific B and T cells fight off the infection. The homeostatic population of lung macrophages includes interstitial macrophages derived from circulating monocytes in addition to alveolar macrophages of embryonic origin [5,6]. Alveolar macrophages were not altered with treatment and were gradually reduced during infection as expected. However, an increase in interstitial macrophages was observed after OM-85-BV treatment and before viral infection [4]. In the verum group, the accumulation of interstitial macrophages in lung tissue after MCoV infection resulted in a more rapid response of interferon type-I signaling. Moreover, RNA sequencing showed that lung tissue from the experimental animals receiving OM-85-BV at day 4 resembled an intermediate stage between healthy and virally infected lung tissue, suggesting a more rapid return to normal tissue homeostasis. To determine whether the modulation of the lung immune system is organ-specific, the researchers analyzed monocytes and splenic macrophages before and during MCoV infection. Regardless of the OM-85-BV treatment, there were no differences in the amount of monocytes in the bloodstream or macrophages in the spleen, neither at baseline nor during MCoV infection. This indicates lung-specific accumulation of interstitial macrophages induced by OM-85-BV pretreatment.

 

 

Improved viral clearance and reduced apoptotic load on the lungs

Viral infections are accompanied by host cell apoptosis [7]. Treated animals showed reduced apoptotic load on lung tissue at days 4 and 10 compared with the control group. Furthermore, the data suggest that pretreatment with OM-85-BV improved the initial response to viral infection and resulted in more rapid clearance of MCoV, probably by inducing type I interferon (IFN). Therefore, baseline and IFN pathway activation levels were measured at days 1 and 2 postinfection. Treatment with OM-85-BV did not increase baseline IFNα levels, but there was a strong and significant induction of IFNα at day 1 in OM-85-BV treated animals (Fig. 1A) [4]. IFNβ was significantly induced in treated animals at day 2 (Fig. 1B) [4]. Overall, the results indicate a strong upregulation of type I IFN response Tag. 1 after treatment with OM-85-BV. At the cellular level, flow cytometric measurement showed that on day. 1 in OM-85-BV-treated animals, particularly CD45+CD64+ macrophages and CD45 non-leukocytes had significantly more interferon-regulatory factor 1 protein than did laboratory mice in the control group.

 

Literature:

  1. Drug Information, www.swissmedicinfo.ch (last accessed Jan. 24, 2022).
  2. Yin J, et al: Int Immunopharmacol 2018; 54: 198-209.
  3. Razi, CH et al: J Allergy Clin Immunol 2010; 126(4):763-769.
  4. Salzmann M, et al: Journal of Innate Immunity 2021; 1-13.
  5. Gomez Perdiguero E, et al: Nature 2015; 518: 547-551.
  6. Schneberger D, Aharonson-Raz K, Singh B: Cell Tissue Res 2011; 343: 97-106.
  7. Herold S, et al: J Exp Med 2008; 205: 3065-3077.

 

HAUSARZT PRAXIS 2022; 17(2): 18

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Bacterial extract
  • Bacterial immunostimulant
  • Broncho-Vaxom
  • Coronavirus
  • Defenses
  • immunological
  • Lung tissue
  • Macrophages
  • MCoV
  • Mouse
  • Mouse model
  • Murin
  • OM-85-BV
  • Respiratory Infection
  • Strengthen
Previous Article
  • Autoimmune diseases of the skin

Diagnosis and monitoring of cutaneous lupus erythematosus (CLE)

  • Congress Reports
  • Dermatology and venereology
  • RX
View Post
Next Article
  • Type 2 diabetes and chronic renal failure (CKD)

Dapagliflozin: risk reduction even in the presence of greatly increased albumin excretion.

  • Congress Reports
  • Endocrinology and Diabetology
  • General Internal Medicine
  • Nephrology
  • Partner Content
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 30 min
  • Chemsex - MSM, sex, chrystal meth & co.

Medical and psychosocial perspectives

    • CME continuing education
    • General Internal Medicine
    • Infectiology
    • Pharmacology and toxicology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • RX
View Post
  • 3 min
  • Bladder cancer

Tuberculosis vaccination reduces recurrences

    • Congress Reports
    • Oncology
    • Pneumology
    • Prevention and health care
    • RX
    • Studies
    • Urology
View Post
  • 4 min
  • Oral JAK-i in atopic dermatitis

Benefits and risks: What does the current data say?

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 17 min
  • Sleep-wake disorders in pneumology practice

Patience, knowledge and persistence in therapy

    • CME continuing education
    • General Internal Medicine
    • Neurology
    • Pneumology
    • RX
View Post
  • 9 min
  • Chronic lung diseases

Sarcopenia and malnutrition in the context of pneumological rehabilitation

    • CME continuing education
    • General Internal Medicine
    • Geriatrics
    • Nutrition
    • Pneumology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 19 min
  • Cardiovascular risk and obesity

Pathomechanisms, secondary prevention and treatment options

    • Cardiology
    • CME continuing education
    • Endocrinology and Diabetology
    • Nutrition
    • RX
    • Sports Medicine
    • Studies
    • Training with partner
View Post
  • 9 min
  • Oxidative stress and neurodegeneration

Insights and therapeutic strategies for Parkinson’s disease

    • Education
    • Neurology
    • Phytotherapy
    • RX
    • Studies
View Post
  • 4 min
  • Biologics for atopic dermatitis

Th2 cytokines in focus: proven and new targets

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Pharmacology and toxicology
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.